We are live on
!
Find out more
VWM
Vigilare Wealth Management Portfolio holdings
AUM
$326M
1-Year Est. Return
21.58%
This Fund
S&P 500
This Quarter
Est. Return
+21.36%
1 Year Est. Return
+21.58%
3 Year Est. Return
+56.88%
5 Year Est. Return
+49.16%
10 Year Est. Return
–
AUM
$98.5M
AUM Growth
+$15M
(+18%)
Cap. Flow
+$39.7K
Cap. Flow
% of AUM
0.04%
Top 10 Holdings %
Top 10 Hldgs %
38.31%
Holding
154
New
40
Increased
14
Reduced
65
Closed
31
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ProShares Short S&P500
SH
|
+$3.79M |
| 2 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$1.68M |
| 3 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$1.18M |
| 4 |
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
|
+$1.11M |
| 5 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.07M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$1.87M |
| 2 |
Vanguard Dividend Appreciation ETF
VIG
|
+$1.74M |
| 3 |
Abbott
ABT
|
+$1.39M |
| 4 |
American Electric Power
AEP
|
+$1.12M |
| 5 |
Bank of America
BAC
|
+$1.04M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.04% |
| 2 | Healthcare | 10.48% |
| 3 | Communication Services | 8.02% |
| 4 | Consumer Discretionary | 7.43% |
| 5 | Consumer Staples | 5.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Zymeworks
ZYME
$1.7B
| $219K | 0.22% |
+6,060
| New | +$223K |
|
102
Caterpillar
CAT
$394B
| $215K | 0.22% |
1,700
-1,427
| -46% | -$169K |
|
103
AbbVie
ABBV
$431B
| $214K | 0.22% |
+2,181
| New | +$192K |
|
104
Marker Therapeutics
MRKR
$18.7M
| $214K | 0.22% |
10,345
-5,041
| -33% | -$110K |
|
|
FOLD
105
DELISTED
Amicus Therapeutics
FOLD
| $213K | 0.22% |
14,100
-4,000
| -22% | -$48.7K |
|
106
Starbucks
SBUX
$120B
| $213K | 0.22% |
2,895
-1,530
| -35% | -$115K |
|
107
Vanguard S&P 500 ETF
VOO
$1.01T
| $213K | 0.22% |
+750
| New | +$202K |
|
|
BCEL
108
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $213K | 0.22% |
+10,020
| New | +$177K |
|
109
Microchip Technology
MCHP
$40.4B
| $211K | 0.21% |
+4,000
| New | +$180K |
|
|
TRIL
110
DELISTED
Trillium Therapeutics Inc.
TRIL
| $211K | 0.21% |
+26,100
| New | +$161K |
|
111
Aurinia Pharmaceuticals
AUPH
$2.07B
| $205K | 0.21% |
12,600
+100
| +0.8% | +$1.6K |
|
112
Sarepta Therapeutics
SRPT
$1.77B
| $203K | 0.21% |
1,265
-1,385
| -52% | -$188K |
|
113
iShares MSCI EAFE Min Vol Factor ETF
EFAV
$5.46B
| $201K | 0.2% |
3,046
-640
| -17% | -$41.5K |
|
114
State Street SPDR S&P Health Care Equipment ETF
XHE
$160M
| $201K | 0.2% |
+2,250
| New | +$187K |
|
|
AMRN
115
Amarin Corp
AMRN
$301M
| $175K | 0.18% |
1,264
-597
| -32% | -$82.1K |
|
116
Ocular Therapeutix
OCUL
$1.92B
| $144K | 0.15% |
+17,300
| New | +$115K |
|
|
AFMD
117
DELISTED
Affimed
AFMD
| $135K | 0.14% |
+2,929
| New | +$81.5K |
|
|
118
CALL
ProShares Short S&P500
SH
$902M
| $123K | 0.12% |
+1,375
| New | +$132K |
|
119
Liberty All-Star Equity Fund
USA
$1.85B
| $116K | 0.12% |
20,200
-2,000
| -9% | -$10.8K |
|
|
UROV
120
DELISTED
Urovant Sciences Ltd.
UROV
| $100K | 0.1% |
+10,200
| New | +$97.8K |
|
121
Nokia
NOK
$52.6B
| $53K | 0.05% |
+12,000
| New | +$45.3K |
|
122
CALL
ProShares UltraShort S&P500
SDS
$394M
| $19K | 0.02% |
+40
| New | +$22.7K |
|
123
Verastem
VSTM
$519M
| $19K | 0.02% |
+917
| New | +$24.3K |
|
|
124
American Electric Power
AEP
$68.2B
| – | – |
-13,955
| Closed | -$1.12M |
|
|
125
Bank of America
BAC
$441B
| – | – |
-48,898
| Closed | -$1.04M |
|
Similar funds
DCM
ECH
AFA
BCM
ISFAN
JHWEPV
CCG
CWM
Vigilare Wealth Management's Q2 2020 Portfolio in Review
As of Q2 2020, Vigilare Wealth Management held 154 positions worth $98.5M, up 18% from $83.6M the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Vigilare Wealth Management's Q2 2020 filing shows 40 new, 14 increased, 65 reduced and 31 closed positions. Its largest new stake was ProShares Short S&P500: 39,488 shares worth $3.53M. The largest sale was JPMorgan Chase, an estimated $1.87M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Communication Services.
- Vigilare Wealth Management's largest Q2 2020 buy was ProShares Short S&P500: 39,488 shares worth $3.53M.
- Vigilare Wealth Management added most to iShares Core S&P Small-Cap ETF in Q2 2020, an estimated $261K increase.
- Vigilare Wealth Management's biggest Q2 2020 reduction was JPMorgan Chase, cutting an estimated $1.87M.
- Vigilare Wealth Management fully exited American Electric Power in Q2 2020, selling an estimated $1.12M.
- Vigilare Wealth Management's ten largest holdings make up 38% of its $98.5M portfolio in Q2 2020.
- Vigilare Wealth Management opened 40 new positions and closed 31 in Q2 2020.
- Vigilare Wealth Management's portfolio value rose 18% quarter-over-quarter to $98.5M.
Based on Vigilare Wealth Management's 13F filing for Q2 2020, filed 20 Jul 2020.